A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model

Jakob Kreye, S. Momsen Reincke, Hans‐Christian Kornau, +40

Cell

Virus-induced senescence is a driver and therapeutic target in COVID-19

Soyoung Lee, Yong Yu, Jakob Trimpert, +45

Nature

Viral PersistenceAgingVirologyCellular SenescenceVirus-induced Senescence +3

SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

Nils C. Gassen, Jan Papies, Thomas Bajaj, +32

Nature Communications

Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters

Nikolaus Osterrieder, Luca D. Bertzbach, Kristina Dietert, +7

Viruses

Viral PersistenceEmerging Infectious DiseasesRespiratory DiseasesAge-dependent ProgressionAnimal Virus +10

ICTV Virus Taxonomy Profile: Herpesviridae 2021

Derek Gatherer, Daniel P. Depledge, Carol A. Hartley, +22

Journal of General Virology

ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion

Georg Jocher, Vincent Grass, Sarah K. Tschirner, +14

EMBO Reports

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

Federico Bertoglio, Viola Fühner, Maximilian Ruschig, +38

Cell Reports

The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection

Jakob Trimpert, Daria Vladimirova, Kristina Dietert, +6

Cell Reports

Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19

Geraldine Nouailles, Emanuel Wyler, Peter Pennitz, +22

Nature Communications

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Yuyong Zhou, Kerry Gilmore, Santseharay Ramírez, +10

Scientific Reports